A calcium channel or angiotensin converting enzyme inhibitor/angiotensin receptor blocker regime to reduced blood pressure variability in acute ischaemic stroke (CAARBS): a feasibility trial
<br><strong>Background: </strong>Trials of lowering blood pressure in patients with acute ischaemic stroke not undergoing thrombolysis have not demonstrated improved outcomes with intervention. Rather than absolute levels, it may be that blood pressure variability is important. How...
Principais autores: | Davison, WJ, Appiah, K, Robinson, TG, McGurgan, IJ, Rothwell, PM, Potter, JF |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Elsevier
2020
|
Registros relacionados
-
Randomised controlled trial of a calcium channel or angiotensin converting enzyme inhibitor/angiotensin receptor blocker regime to reduce blood pressure variability following ischaemic stroke (CAARBS): a protocol for a feasibility study
por: Robinson, T, et al.
Publicado em: (2019) -
The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Myla E. Moretti, et al.
Publicado em: (2012-01-01) -
Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Contrast-Induced Nephropathy
por: Letian Zhou, et al.
Publicado em: (2014-03-01) -
Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
por: Hyun Woo Lee, et al.
Publicado em: (2021-03-01) -
Monitoring and controlling blood pressure after stroke and transient ischaemic attack
por: McGurgan, I
Publicado em: (2021)